CRISPR Therapeutics AG (CRSP): A Bull Case Theory
We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on Two Natural Cap’s Substack. In this article, we will summarize the bulls’ thesis on CRSP.
Crispr Therapeutics Ag (CRSP)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 10,165,400 | $345,928,566 | +14% | 3.46% |
| 2. | Orbis Investment Management William B. Gray | 1,562,932 | $53,186,576 | +6% | 0.3% |
| 3. | EcoR1 Capital Oleg Nodelman | 1,389,276 | $47,277,062 | 2.8% | |
| 4. | SR One Capital Simeon George | 1,048,951 | $35,695,803 | 9.17% | |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 797,200 | $27,128,716 | +841% | 0.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $44.85 | 7,000 | $313,947.90 | 7,000 | 2025-02-26 | Filing | |
| $24.95 | 27,461 | $685,116.25 | 5,380,940 | 2018-12-27 | Filing | |
| $24.89 | 12,737 | $317,077.43 | 5,353,479 | 2018-12-26 | Filing | |
| $24.97 | 53,655 | $1,339,695.60 | 5,340,742 | 2018-12-24 | Filing | |
| $23.18 | 11,742 | $272,139.64 | 5,287,087 | 2018-12-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $35.94 | 3,932 | $141,316.08 | 6,068 | 2025-05-29 | Filing | |
| $41.23 | 10,031 | $413,578.13 | 195,085 | 2025-03-21 | Filing | |
| $41.23 | 1,714 | $70,668.22 | 10,544 | 2025-03-21 | Filing | |
| $41.23 | 2,197 | $90,582.31 | 16,767 | 2025-03-21 | Filing | |
| $41.23 | 3,185 | $131,317.55 | 81,729 | 2025-03-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,073,118 | $206,668,206 | 0.04% | |
| 2. | 2,613,539 | $88,938,732 | 0% | |
| 3. | 2,539,889 | $86,432,423 | 0.06% | |
| 4. | 2,539,889 | $86,330,827 | 1.11% | |
| 5. | 2,411,262 | $82,055,246 | 0% |
News See All
12 Most Promising Biotech Stocks According to Wall Street Analysts
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
CRISPR Therapeutics AG (CRSP): A Bull Case Theory
We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on wallstreetbets Subreddit Page by MADD-Scientis. In this article, we will summarize the bulls’ thesis on CRSP.
12 Most Shorted Stocks in 2025
Reuters reported that President Trump’s tariffs have impacted the broader stock markets, weighing on investors’ sentiments, as worries related to the economic slowdown drove a market sell-off which...
Ark Invest Stock Portfolio: Top 10 Stocks to Buy
ARK Investment Management LLC, commonly known as ARK Invest, is an American investment management firm headquartered in St. Petersburg, Florida.
10 Oversold Pharma Stocks to Buy According to Analysts
On February 20, Emily Field, Head of European Pharma Research at Barclays, appeared on CNBC to discuss the dynamics of the pharmaceutical sector, the impact of US tariffs, and the performance of obesity...
12 Most Oversold Healthcare Stocks to Buy Now
Healthcare costs and spending have been rising in the US. The Centers for Medicare & Medicaid Services reported that healthcare spending in the US reached $4.9 trillion in 2023, up 7.5% from 2022.
Cathie Wood's Stock Portfolio: 2025 Stock Picks
Cathie Wood is one of Wall Street's most contentious figures.
12 Biotech Stocks with the Biggest Upside Potential
While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.
Top 11 CRISPR Stocks to Invest In
The pharmaceutical industry is buzzing with innovation, driven by the need for new treatments, tackling unmet medical challenges, and leveraging cutting-edge technologies like pharmacogenomics, digital...
Billionaire Hedge Funds
